Biotechnology Value Fund
North America, California, United States, San Francisco
Description
Biotechnology Value Fund is an evergreen fund specializing in early stage financing. It focuses on undervalued investment
Investor Profile
Biotechnology Value Fund has made 136 investments, with 13 in the past 12 months and 26% as lead.
Stage Focus
- Post Ipo Equity (38%)
- Series B (27%)
- Series A (13%)
- Series C (11%)
- Series Unknown (5%)
- Series D (2%)
- Post Ipo Debt (1%)
- Convertible Note (1%)
- Post Ipo Secondary (1%)
- Private Equity (1%)
Country Focus
- United States (81%)
- Switzerland (6%)
- Canada (4%)
- France (3%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (1%)
- Israel (1%)
- Ireland (1%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Germany (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical
- Biopharma
- Life Science
- Oncology
- Medical Device
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
